FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren’s syndrome

OBJECTIVES: To assess the usefulness of [(18)F]-fluorodeoxyglucose (FDG)-PET/CT (i) to discriminate between primary SS (pSS) patients with and without lymphomas and (ii) to evaluate systemic disease activity in pSS. METHODS: ACR-EULAR-positive pSS patients who underwent FDG-PET/CT were included. Sca...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ginkel, Martha S, Arends, Suzanne, van der Vegt, Bert, Nijland, Marcel, Spijkervet, Fred K L, Vissink, Arjan, Kroese, Frans G M, Glaudemans, Andor W J M, Bootsma, Hendrika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547509/
https://www.ncbi.nlm.nih.gov/pubmed/36759907
http://dx.doi.org/10.1093/rheumatology/kead071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547509/
https://www.ncbi.nlm.nih.gov/pubmed/36759907
http://dx.doi.org/10.1093/rheumatology/kead071

Ejemplares similares